Rating Rationale
May 29, 2021 | Mumbai
United India Insurance Company Limited
Ratings Reaffirmed
 
Rating Action
Rs.900 Crore Subordinated DebtCRISIL AAA/Negative (Reaffirmed)
Corporate Credit RatingCCR AAA/Negative (Reaffirmed)
Note: None of the Directors on CRISIL Ratings Limited’s Board are members of rating committee and thus do not participate in discussion or assignment of any ratings. The Board of Directors also does not discuss any ratings at its meetings.
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings has reaffirmed its Corporate Credit Rating (CCR) and rating on subordinated debt issue of United India Insurance Company Ltd (United India Insurance) at ‘CCR AAA/Negative’ and ‘CRISIL AAA/Negative’, respectively.

The rating on the hybrid instrument remains centrally based on forbearance granted by the Insurance Regulatory and Development Authority of India (IRDAI) to United India Insurance from adhering to provisions 3(vii) and 5(vii) of Insurance Regulatory and Development Authority of India (Other Forms of Capital) Regulations, 2015, for this specific subordinated debt issue of Rs 900 crore. The forbearance allows the company to service the interest or coupon payments to the investors in the issue throughout the life of the instrument, irrespective of solvency ratio. IRDAI has also granted forbearance against provision 14 of the regulation and has allowed the company to issue subordinated debt to the extent of 25% of its networth as on September 30, 2018.

The ratings continue to reflect the company's strategic importance to, and expectation of strong support from, the Government of India, in addition to its established market position in the Indian general insurance industry. These strengths are partially offset by the low cushion in solvency ratio and dependence of capitalisation on equity infusion by the government.

The Negative outlook continues to reflect weakness in the underwriting performance of United India Insurance over the medium term, thereby constraining its overall profitability, capitalisation and solvency position.

With a track record of over 75 years, the company ranked as the second-largest insurer in the industry based on the gross premiums written during fiscal 2021, with a market share of 8.4%. As macro growth prospects remained subdued after Covid-19, its gross direct premium de-grew by 4.6% over fiscal 2021 against industrial growth of 5.2%. 

The company honoured Rs 896.7 crore of claims in the fiscal as coverage for Covid-19 cases. Apart from the standard product, Corona Kavach, these claims were also reported from the traditional mediclaim policyholders. However, claims for non-Covid illnesses/casualties were lower during the year. Instances of claim reports for other segments were also lower during fiscal 2021 due to restricted public activity and vehicular traffic. This led to a reduced claims ratio of 89.9% for the first nine months of fiscal 2021 compared to 106.7% for the corresponding period previous fiscal. Hence, the combined ratio improved to 122.7% from 135.4%.

Since the severity and frequency of casualties are higher in the second wave of the pandemic, penetration of health insurance has increased in the last one year. Hence, an upward revision in Covid-19 coverage products could be in order to adequately factor in the increased risks. Over the medium term, losses incurred from the pandemic and their impact on the overall underwriting performance remain key monitorables.

Reported networth was Rs 3,962 crore on December 31, 2020, which, in addition to the balance in fair value change account, further increases to Rs 5,920 crore. Since the fourth quarter of fiscal 2020, the company has received Rs 3,655 crore as equity capital from the government, which has provided some cushion to networth. Reported solvency, including 85% of the balance in fair value change account, stood at 1.38 times on December 31, 2020 (0.30 time as on March 31, 2020). However, ability to accelerate and sustain the improvement in underwriting performance so as to self-sustain capital position in solvency remains critical in the long run. For the nine months ended December 31, 2020, underwriting deficit of Rs 2,263 crore led to an overall loss of Rs 452 crore. However, this was partly offset by Rs 2,077 crore of investment income.

For fiscal 2022, growth in new business premium for larger segments such as motor insurance could remain muted for a longer stretch as revival in new sales volumes in the auto sector will happen only gradually once lockdowns across states are lifted. Renewal premiums from the retail segment could also been impacted on account of job losses and pay cuts. For the health segment, which grew 16.9% year-on-year in fiscal 2021, the prospects will remain strong on the back of increased market awareness and demand for multiple covers. In a scenario where pricing for Covid-19 policies is revised upwards, growth in this segment could be higher than last fiscal. However, with the increasing ticket size of Covid-19 claims, the impact of actual losses borne by the insurers after the second wave remains to be seen.

Analytical Approach

CRISIL Ratings first arrived at the corporate credit rating of United India Insurance, which is an indication of its ability to honour its debt and policyholder obligations. For arriving at the CCR, CRISIL Ratings has factored in the expectation of strong government support, in addition to the assessment of the company’s business, financial, and management risk profiles. The subordinated debt instrument is then tested for additional risk factors to determine whether its rating should be the same as, or lower than, the CCR. The extent of cushion that United India Insurance intends to maintain in the solvency ratio over and above the regulatory stipulation on a steady state basis is taken into consideration to arrive at the rating on the subordinated debt instrument.

 

The regulatory forbearance granted to the company virtually eliminates the risk factor for its subordinated debt issue as it is allowed to service the interest or coupon payments throughout the life of the instrument, irrespective of the solvency ratio.

Key Rating Drivers & Detailed Description

Strengths:

* Strategic importance to, and expectation of strong support from, the Government of India

United India Insurance is expected to receive strong government support on a steady state basis, driven by its established track record and extensive market reach that make it strategically important to the government. The importance of the general insurance sector, especially government-owned insurers such as United India Insurance, can also be perceived in the context of the government plan to materially enhance insurance penetration in the long term. As a demonstration of their strategic importance to the government and the latter’s stance on extending timely support, public general insurers were allotted Rs 12,450 crore of capital by the government in July 2020 (including the Rs 2,500 crore already infused in March 2020). United India Insurance, National Insurance Company Ltd (National) and The Oriental Insurance Company (Oriental) cumulatively received Rs 2,500 crore in fiscal 2020 and Rs 9,950 crore in fiscal 2021. Of this, United India Insurance received Rs 50 crore and Rs 3,605 crore, respectively.


Along with the capital allocation, the government also announced its decision of shelving the merger process of Oriental with National and United, and focusing on improving the standalone financial risk profiles of these entities. CRISIL Ratings also takes note of the government plan announced in the last annual budget to privatise one of the public general insurers in the long term, and would continue to monitor developments in this aspect.

 

* Established market position

United India Insurance is the second-largest general insurance company in India with a market share of around 8.4% based on gross premiums originated during fiscal 2021. The company underwrote gross premium of Rs 16,711 crore for fiscal 2021, registering a negative growth of 4.6% against industry-level growth of 5.2%. This reduction primarily stemmed from negative growth in key segments such as motor and crop, which is applicable for the entire sector. Over fiscal 2021, the general insurance sector witnessed negative growth of 1.7% in the motor segment and 3.4% in the crop segment. Against this, United India Insurance motor premium de-grew by 11.2% whereas premium from the crop segment de-grew by 53.8%. In the health segment, wherein the industry grew at a robust rate of 13.4% during fiscal 2021 driven by increased demand for products due to the pandemic, health insurance portfolio of the company grew at 16.9%. General insurance sector in the fire segment grew at 28.1%, stimulated by standardisation of rates across players. However, United India Insurance witnessed a growth of 13.7%

 

Over the next fiscal, the company plans to grow at 5-7% with the underlying premise that the second wave of the pandemic should tail out by the end of the first quarter of fiscal 2022. This growth will be driven by the motor, health and fire segments.

 

Weakness:

*Reported solvency remains below regulatory stipulation and capitalisation dependent on equity infusion by the government

Capitalisation and solvency position of United India Insurance remains strained. On March 31, 2020, the company reported a solvency ratio of 0.30 time (factoring in 100% of the balance in fair value change account) against 1.52 times as on March 31, 2019. The sharp decline was because of the reduction in fair value change balance imposed by volatility in equity markets to negative Rs 618 crore from Rs 3,454 crore. With capital infusion by the government and gradual recovery in equity markets, solvency ratio (factoring in 85% of the balance in fair value change account as on that date) recovered to 1.38 times as on December 31, 2020. Reported networth also increased to Rs 3,962 crore as on December 31, 2020, from Rs 1,511 crore as on March 31, 2020.

 

Over the medium term, capitalisation and solvency position are expected to remain dependent on equity support from the government and the fair value change balance of the company. Additional comfort is drawn from regulatory relaxations allowed by the government to the company, in terms of including fair value change balance in its solvency reporting. The company aims to restore its solvency position to 1.5 times (excluding fair value change balance) over the next 5-6 quarters. In the meantime, delay in improvement in underwriting performance and overall profitability, thereby significantly impacting capital and solvency position, will remain key rating sensitivity factor.

 

*Modest underwriting performance

Underwriting performance had moderated after fiscal 2017 because of additional provisioning requirement in the motor third party segment. After fiscal 2017, however, underwriting performance had improved momentarily in fiscal 2018; however, it has remained weak since then. For fiscal 2020, the company reported an underwriting deficit of Rs 4,398 crore compared to a Rs 5,024 deficit in fiscal 2019. Correspondingly, the combined ratio also improved marginally to 132.0% from 136.9% driven by improvement in claim ratio to 101.5% from 109.4%. However, some of this improvement was offset by the increase in expense ratio to 30.6% from 27.5%.

 

For the nine months ended December 31, 2020, underwriting deficit stood at Rs 2,263 crore, lower than the deficit of Rs 3,477 crore for the corresponding period previous fiscal. Combined ratio for the first nine months of fiscal 2021 stood at 122.7% - better than 132.0% in the corresponding period in fiscal 2020 - driven by reduced instances of claims due to the lockdown. While claims ratio for fiscal 2021 is not expected to increase materially from current levels, with restoration of operational activity – mainly increased vehicular activity – claims would increase to pre-Covid levels.

 

Underwriting performance is expected to remain modest over the medium term and improve only gradually in the long term. However, with increased penetration of health insurance products over the last 3-4 quarters alongside surge in Covid-19 casualties, losses from the pandemic are expected to have risen sharply over the first few months of fiscal 2022. However, similar to the last fiscal, its impact on the overall claims ratio would be net off by reduction in other regular claims (such as motor and fire).

 

Any significant deterioration in the underwriting performance straining earnings profile and capitalisation will be a key rating sensitivity factor.

 

* Moderation in profitability metrics posing pressure on capital position and profitability

Earnings profile has remained modest because of average underwriting performance. Despite a stable investment income of Rs 3,177 crore for fiscal 2020, the company reported a net loss of Rs 1,486 crore for the fiscal, against loss of Rs 1,878 crore in the previous fiscal. These losses was a factor of higher underwriting deficit for both the fiscals.

 

For the nine months ended December 31, 2020, while underwriting deficit improved from the corresponding period previous fiscal, income from investments remained almost stable. For the nine months of fiscal 2021, the company earned Rs 2,077 crore as income from investments compared to Rs 1,979 crore earned in the corresponding period previous fiscal. With underwriting loss of Rs 2,2,63 crore, net loss for the nine months ended December 31, 2021, was Rs 452 crore against Rs 1,359 crore for the same period in fiscal 2020.

 

Ability to improve underwriting performance, such that overall profitability is revived and capital position and solvency are sustained at strong levels, will remain a key monitorable.

Liquidity: Superior

Almost 97% of the debt investments were in securities rated ‘AA’ or higher or in sovereign securities as on December 31, 2020. Healthy liquid investments of Rs 14,088 crore also support liquidity. Government securities accounted for 60% of the investment portfolio based on market value as on December 31, 2020. Liquid assets to technical reserves ratio[1] remains adequate at 91% and 53% as on December 31 and March 31, 2020, respectively.

Outlook\: Negative

Despite improvement after capital infusion by the government, capital position of United India Insurance is expected to remain vulnerable because of weak underwriting performance and modest earnings profile. Nonetheless, credit risk profile remains centrally driven by expectation of strong and continued support from the government given the high strategic importance of the company to the latter, and is supported by its established market position in the general insurance industry and sustenance of sound portfolio quality. The rating on the subordinated debt instrument also factors in the regulatory forbearance granted to United India Insurance.

Rating Sensitivity factors

Upward Factors

  • Revival in reported solvency ratio to above 1.5 times (excluding balance in fair value change account) and maintaining it at above regulatory stipulation on a steady state basis
  • Substantial and sustained improvement in underwriting performance leading to improvement in earnings and networth

 

Downward Factors

  • Continued moderation in underwriting performance, leading to an adverse impact on profitability, and solvency margin remaining below 1.5 times for a long time
  • Sizeable reduction in extent of ownership or strategic importance to the Government of India

About the Company

United India Insurance is the second-largest non-life insurance company wholly owned by the Government of India. The company commenced operations in 1938. After nationalisation of the general insurance business in 1972, it became one of the four subsidiaries of General Insurance Company of India (GIC). In December 2000, the subsidiaries of GIC were restructured as independent companies and GIC became a national reinsurer. United India Insurance has head office in Chennai and over 2,000 offices across the country.

 

 

[1] Liquid assets = Cash balance + investments in liquid mutual funds + government securities

Technical reserves = Reserve for unexpired risks, premium deficiency and outstanding claims.

Key Financial Indicators

 

 

9M2021

FY 2020

FY 2019

FY 2018

Gross direct premium written

Rs.Crore

11,893

17,515

16,420

17,429

Profit/ (loss) after tax

Rs.Crore

(452)

(1486)

(1878)

1,003

Combined ratio

%

122.7%

132.0%

136.9%

120.7%

Solvency ratio

Times

1.38#

0.30*

1.52*

1.54

*includes 100% of fair value change balance

#includes 85% of fair value change balance

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings` complexity levels are assigned to various types of financial instruments and are included (where applicable) in the 'Annexure - Details of Instrument' in this Rating Rationale.

CRISIL Ratings will disclose complexity level for all securities - including those that are yet to be placed - based on available information. The complexity level for instruments may be updated, where required, in the rating rationale published subsequent to the issuance of the instrument when details on such features are available.

For more details on the CRISIL Ratings` complexity levels please visit www.crisilratings.com. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of Instrument

Date of Allotment

Coupon
Rate (%)

Maturity Date

Issue Size
(Rs.Cr)

Complexity Level

Rating Assigned  with Outlook

INE346Z08011

Subordinated Debt

2-Feb-18

8.25%

2-Feb-28

900

Complex

CRISIL AAA/Negative

NA Corporate Credit Rating NA NA NA NA NA CCR AAA/Negative

 

Annexure - Rating History for last 3 Years
  Current 2021 (History) 2020  2019  2018  Start of 2018
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Corporate Credit Rating LT 0.0 CCR AAA/Negative   -- 29-05-20 CCR AAA/Negative   --   -- --
Subordinated Debt LT 900.0 CRISIL AAA/Negative   -- 29-05-20 CRISIL AAA/Negative 30-01-19 CRISIL AAA/Stable 25-01-18 CRISIL AAA/Stable CRISIL AAA/Stable
      --   -- 31-01-20 CRISIL AAA/Negative   --   -- --
Financial Strength rating LT   --   -- 29-05-20 Withdrawn 30-01-19 CRISIL AAA/Stable   -- --
      --   -- 31-01-20 CRISIL AAA/Negative   --   -- --
All amounts are in Rs.Cr.
Note: Annexure has been updated on 29-Apr-23 for Complexity level of the instrument

  

Criteria Details
Links to related criteria
Rating Criteria for General Insurance Companies
CRISILs criteria for Hybrid Issuances of General Insurance Companies
Criteria for Notching up Stand Alone Ratings of Entities Based on Government Support

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Krishnan Sitaraman
Senior Director and Deputy Chief Ratings Officer
CRISIL Ratings Limited
D:+91 22 3342 8070
krishnan.sitaraman@crisil.com


Ajit Velonie
Director
CRISIL Ratings Limited
D:+91 22 4097 8209
ajit.velonie@crisil.com


Abhishek Narang
Manager
CRISIL Ratings Limited
B:+91 22 3342 3000
Abhishek.Narang@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited, an S&P Global Company)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 

 



About CRISIL Limited

CRISIL is a leading, agile and innovative global analytics company driven by its mission of making markets function better. 

It is India’s foremost provider of ratings, data, research, analytics and solutions with a strong track record of growth, culture of innovation, and global footprint.

It has delivered independent opinions, actionable insights, and efficient solutions to over 100,000 customers through businesses that operate from India, the US, the UK, Argentina, Poland, China, Hong Kong and Singapore.

It is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.

For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL's privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale ('report') that is provided by CRISIL Ratings Limited ('CRISIL Ratings'). To avoid doubt, the term 'report' includes the information, ratings and other content forming part of the report. The report is intended for the jurisdiction of India only. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. In preparing our report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. The rating contained in the report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way. CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains.

Neither CRISIL Ratings nor its affiliates, third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively, 'CRISIL Ratings Parties') guarantee the accuracy, completeness or adequacy of the report, and no CRISIL Ratings Party shall have any liability for any errors, omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the report. EACH CRISIL RATINGS PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any), are made available on its website, www.crisilratings.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee - more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and/or relies on in its reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For details please refer to:
https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public website, www.crisilratings.com. For latest rating information on any instrument of any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301.

This report should not be reproduced or redistributed to any other person or in any form without prior written consent from CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings is a wholly owned subsidiary of CRISIL Limited.

 

 

CRISIL Ratings uses the prefix 'PP-MLD' for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisil.com/en/home/our-businesses/ratings/credit-ratings-scale.html